These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29603817)

  • 21. Aflatoxin exposure in viral hepatitis patients in Turkey.
    Mizrak D; Engin B; Onder FO; Yener B; Bektaş M; Biyikli Z; Idilman R; Cinar K; Karayalçin K; Ersöz S; Karayalçin S; Ozden A; Yurdaydin C; Yazihan N; Ataoğlu H; Bozkaya H; Uzunalimoğlu O
    Turk J Gastroenterol; 2009 Sep; 20(3):192-7. PubMed ID: 19821201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular carcinoma surveillance at 4- vs. 12-month intervals for patients with chronic viral hepatitis: a randomized study in community.
    Wang JH; Chang KC; Kee KM; Chen PF; Yen YH; Tseng PL; Kuo YH; Tsai MC; Hung CH; Chen CH; Tai WC; Tsai LS; Chen SC; Lin SC; Lu SN
    Am J Gastroenterol; 2013 Mar; 108(3):416-24. PubMed ID: 23318478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening.
    Robotin MC; Kansil M; Howard K; George J; Tipper S; Dore GJ; Levy M; Penman AG
    J Hepatol; 2009 May; 50(5):990-8. PubMed ID: 19303657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low adherence of HIV providers to practice guidelines for hepatocellular carcinoma screening in HIV/hepatitis B coinfection.
    Hearn B; Chasan R; Bichoupan K; Suprun M; Bagiella E; Dieterich DT; Perumalswami P; Branch AD; Huprikar S
    Clin Infect Dis; 2015 Dec; 61(11):1742-8. PubMed ID: 26240206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocellular carcinoma surveillance rates in commercially insured patients with noncirrhotic chronic hepatitis B.
    Goldberg DS; Valderrama A; Kamalakar R; Sansgiry SS; Babajanyan S; Lewis JD
    J Viral Hepat; 2015 Sep; 22(9):727-36. PubMed ID: 25581816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 'We can bear it!' Unpacking barriers to hepatocellular carcinoma screening among patients with hepatitis B: A qualitative study.
    Li C; Lu X; Xiao J; Chan CWH
    J Clin Nurs; 2022 Nov; 31(21-22):3130-3143. PubMed ID: 34816510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
    Kew MC
    Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimisation of hepatocellular carcinoma surveillance in patients with viral hepatitis: a quality improvement study.
    Kennedy NA; Rodgers A; Altus R; McCormick R; Wundke R; Wigg AJ
    Intern Med J; 2013 Jul; 43(7):772-7. PubMed ID: 23611607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary hepatocellular carcinoma and viral hepatitis B and C infection in Bangladeshi subjects.
    Zaman S; Khan M; Alam K; Williams R
    J Trop Med Hyg; 1995 Feb; 98(1):64-8. PubMed ID: 7861482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma.
    Riveiro-Barciela M; Tabernero D; Calleja JL; Lens S; Manzano ML; Rodríguez FG; Crespo J; Piqueras B; Pascasio JM; Comas C; Gutierrez ML; Aguirre A; Suárez E; García-Samaniego J; Rivero M; Acero D; Fernandez-Bermejo M; Moreno D; Sánchez-Pobre P; de Cuenca B; Moreno-Palomares JJ; Esteban R; Buti M
    Dig Dis Sci; 2017 Mar; 62(3):784-793. PubMed ID: 28078526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar.
    Kim YA; Trinh S; Thura S; Kyi KP; Lee T; Sze S; Richards A; Aronsohn A; Wong GLH; Tanaka Y; Dusheiko G; Nguyen MH
    PLoS One; 2017; 12(8):e0181603. PubMed ID: 28797080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: effects on health services utilisation.
    Robotin MC; Kansil MQ; George J; Howard K; Tipper S; Levy M; Phung N; Penman AG
    BMC Health Serv Res; 2010 Jul; 10():215. PubMed ID: 20663140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
    Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study.
    Seo SI; Choi HS; Choi BY; Kim HS; Kim HY; Jang MK
    J Med Virol; 2014 Jan; 86(1):124-30. PubMed ID: 24127328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rising incidence of hepatitis B-related hepatocellular carcinoma in South Australia: 1996-2010.
    Chinnaratha MA; Graham C; Fraser RJ; Woodman RJ; Wigg AJ
    Intern Med J; 2016 Aug; 46(8):902-8. PubMed ID: 27130077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Family physicians' knowledge and screening of chronic hepatitis and liver cancer.
    Ferrante JM; Winston DG; Chen PH; de la Torre AN
    Fam Med; 2008 May; 40(5):345-51. PubMed ID: 18465284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population.
    Sherman M; Peltekian KM; Lee C
    Hepatology; 1995 Aug; 22(2):432-8. PubMed ID: 7543434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.